Concerning galectin-2, a recent study demonstrated that it plays a crucial role in TNBC by contributing to the formation of an immunosuppressive microenvironment, possibly following the release of its form extracellular by the tumor cell (39). This evidence concerns the gene LGALS2 and neoplasm.